Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orelabrutinib and Pomalidomide with miniCHOP-like Regimen in Elderly DLBCL
NCT05809180Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2023
- Primary completion
- Jul 2025
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of orelabrutinib, pomalidomide in diffuse large B-cell lymphoma (DLBCL), sponsored by First Affiliated Hospital of Soochow University. Started Jan 2023; status: recruiting.
02
Drugs
orelabrutinibpomalidomide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT05809180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05809180.